IMU-856
Small molecule
Evidence outlook
No clinical trials on ClinicalTrials.gov
No clinical trial of this drug is registered on ClinicalTrials.gov, so there is nothing to grade. Studies run outside that registry are not tracked here.
How the evidence outlook works ↗
Featured trials
The studies most instrumental to this drug's clinical progression, individually graded on design and result. The complete registry, including every study not featured here, is listed below.
No matching registered study is currently available for this indication; source coverage requires resolution.
No registered study of this drug names Celiac Disease in its conditions or title.
0 registry matches · 0 candidates
All registered studies
Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded.
No registered studies found. Not yet ingested, or none registered.
Competitive landscape
Other SIRT6 drugs
1 other tracked programme targets this mechanism.
This drug's own stage for Celiac Disease: Stage not on record. Competitors below are sorted furthest-along first.
| Drug | Stage | Modality | Mechanism | Evidence signal | Reported efficacygraded featured trials | |
|---|---|---|---|---|---|---|
| IMU-856: this drug | Stage not on record | Small molecule | SIRT6 | not yet graded | No reviewed efficacy summary in this indication | |
| Forvisirvat | Phase 2(overall) | Small molecule | SIRT6 | Partial signal(overall) | No reviewed efficacy summary in this indication | |
| TAK-227 | Phase 2 | Small molecule | Transglutaminase 2 | not yet graded | No reviewed efficacy summary in this indication |
Upcoming events
No upcoming readouts on record for this asset.